Earth Vision Bio

Earth Vision Bio is a clinical-stage biotechnology company focused on developing innovative drug delivery systems for the treatment of chronic ophthalmic diseases. The company's core technology is a refillable, implantable micro-pump designed to provide sustained, controlled release of therapeutic agents directly into the eye. This platform aims to reduce the burden of frequent intravitreal injections for patients with conditions such as wet age-related macular degeneration and diabetic macular edema. By improving treatment adherence and maintaining consistent drug levels, Earth Vision Bio seeks to enhance visual outcomes and patient quality of life. The technology originated from collaborative research between the California Institute of Technology and the University of Southern California.